Perinatal characteristics in relation to incidence of and mortality from prostate cancer

被引:79
|
作者
Ekbom, A
Hsieh, CC
Lipworth, L
Wolk, A
Ponten, J
Adami, HO
Trichopoulos, D
机构
[1] UNIV UPPSALA, DEPT PATHOL, S-75185 UPPSALA, SWEDEN
[2] UNIV MASSACHUSETTS, MED CTR, CTR CANC, WORCESTER, MA 01605 USA
[3] HARVARD UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, BOSTON, MA 02115 USA
[4] HARVARD UNIV, SCH PUBL HLTH, CTR CANC PREVENT, BOSTON, MA 02115 USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 1996年 / 313卷 / 7053期
关键词
D O I
10.1136/bmj.313.7053.337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To test the hypothesis that factors causing morbidity and mortality from prostate cancer may operate in utero. Design-Matched case-control study of singleton men born between 1874 and 1946 at one hospital. Setting-Uppsala University Hospital. Subjects-250 patients with prostate cancer and 691 controls, including 80 patients who died from prostate cancer and their 196 matched controls. Main outcome measures-Mother's age at menarche, parity, pre-eclampsia or eclampsia before delivery, age at delivery and socioeconomic status; case or control's birth length and weight, placental weight, prematurity derived from gestational age, and presence of jaundice. Results-Both pre-eclampsia (odds ratio 0, 95% confidence interval 0 to 0.71) and prematurity (0.31, 0.09 to 1.04) were inversely associated with incidence of prostate cancer. Among subjects born full term, placental weight, birth weight, and ponderal index (weight/height(3)) showed non-significant positive associations with prostate cancer incidence, and stronger associations with mortality. Conclusion-Prenatal exposures that are likely correlates of pregnancy hormones and other growth factors are important in prostate carcinogenesis and influence the natural course as well as the occurrence of this cancer.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 50 条
  • [31] Prostate cancer incidence, mortality, total and free prostate specific antigen
    Bantis, Athanasios
    Vasiliou, Olga
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2009, 12 (02): : 106 - 109
  • [32] International Variation in Prostate Cancer Incidence and Mortality Rates
    Center, Melissa M.
    Jemal, Ahmedin
    Lortet-Tieulent, Joannie
    Ward, Elizabeth
    Ferlay, Jacques
    Brawley, Otis
    Bray, Freddie
    EUROPEAN UROLOGY, 2012, 61 (06) : 1079 - 1092
  • [33] Aspirin and Prostate Cancer Incidence and Mortality-Letter
    Mormile, Raffaella
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (05) : 1000 - 1000
  • [34] Disparities in prostate cancer incidence and mortality rates: Solvable or not?
    Badal, Simone
    Aiken, William
    Morrison, Belinda
    Valentine, Henkel
    Bryan, Sophia
    Gachii, Andrew
    Ragin, Camille
    PROSTATE, 2020, 80 (01): : 3 - 16
  • [35] Incidence and mortality trends of prostate cancer in southern Thailand
    Alvarez, Christian
    Virani, Shama
    Meza, Rafael
    Rozek, Laura
    Sriplung, Hutcha
    Mondul, Alison M.
    CANCER RESEARCH, 2016, 76
  • [36] Racial differences in prostate cancer incidence and mortality.
    Bjurlin, Marc
    Guinan, Patrick
    Christensen, Kevin
    Rubenstein, Marvin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Interpreting recent trends in prostate cancer incidence and mortality
    Gann, PH
    EPIDEMIOLOGY, 1997, 8 (02) : 117 - 120
  • [38] Prostate Cancer Incidence and Mortality in Barbados, West Indies
    Hennis, Anselm J. M.
    Hambleton, Ian R.
    Wu, Suh-Yuh
    Skeete, Desiree H. A.
    Nemesure, Barbara
    Leske, Andm. Cristina
    PROSTATE CANCER, 2011, 2011
  • [39] The Rising Incidence and Mortality of Prostate Cancer in Belgrade Population
    Jankovic, Janko
    Sipetic, Sandra
    COLLEGIUM ANTROPOLOGICUM, 2011, 35 (02) : 499 - 503
  • [40] Ethnic belief differences in the incidence and mortality of prostate cancer
    Guinan, Patrick
    Ongbueco, Kiana
    Rubenstein, Marvin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)